NCT03145025View on ClinicalTrials.gov

Corneal Endothelial Cell Density in Eyes Treated With a Fluocinolone Acetonide Intravitreal Implant

CompletedOBSERVATIONAL
Enrollment

3

Participants

Timeline

Start Date

July 14, 2017

Primary Completion Date

September 10, 2018

Study Completion Date

March 22, 2019

Conditions
Uveitis, Posterior
Interventions
DEVICE

Retisert

Intravitreal Implant

DRUG

Fluocinolone Acetonide Intravitreal Implant

Intravitreal Implant

Trial Locations (1)

02114

Valeant Site 001, Boston

All Listed Sponsors
lead

Bausch & Lomb Incorporated

INDUSTRY

NCT03145025 - Corneal Endothelial Cell Density in Eyes Treated With a Fluocinolone Acetonide Intravitreal Implant | Biotech Hunter | Biotech Hunter